Alzheimer's disease as homeostatic responses to age-related myelin breakdown

[1]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[2]  Paul M. Thompson,et al.  Lifespan trajectory of myelin integrity and maximum motor speed , 2010, Neurobiology of Aging.

[3]  Xianlin Han,et al.  Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease , 2010, Neurobiology of Aging.

[4]  R. Schnaar,et al.  Myelin‐associated glycoprotein and its axonal receptors , 2009, Journal of neuroscience research.

[5]  M. Nobuyoshi,et al.  Progranulin expression in advanced human atherosclerotic plaque. , 2009, Atherosclerosis.

[6]  Yanbo Zhang,et al.  Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease , 2009, Neurobiology of Aging.

[7]  A. Diaspro,et al.  Evidence for aerobic ATP synthesis in isolated myelin vesicles. , 2009, The international journal of biochemistry & cell biology.

[8]  Qing X Yang,et al.  MRI and histological analysis of beta‐amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice , 2009, Journal of magnetic resonance imaging : JMRI.

[9]  M. Ynsa,et al.  A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease. , 2009, Biochemical and biophysical research communications.

[10]  Marie-Claude Potier,et al.  Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.

[11]  Norbert Schuff,et al.  Alzheimer’s Disease Neuroimaging Initiative: A one-year follow up study using Tensor-Based Morphometry correlating degenerative rates, biomarkers and cognition , 2009 .

[12]  V. Mathura,et al.  Apolipoprotein E-genotype dependent hippocampal and cortical responses to traumatic brain injury , 2009, Neuroscience.

[13]  J. Busciglio,et al.  Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta , 2009, Proceedings of the National Academy of Sciences.

[14]  B. Todorich,et al.  Oligodendrocytes and myelination: The role of iron , 2009, Glia.

[15]  C. Jack,et al.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.

[16]  Huaxi Xu,et al.  Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription , 2009, Proceedings of the National Academy of Sciences.

[17]  John Q. Trojanowski,et al.  Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases , 2009, Journal of Neurology.

[18]  D. Berlau,et al.  APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old , 2009, Neurology.

[19]  Kanzo Suzuki,et al.  Biochemical characterization of tau protein and its associated syndapin 1 and protein kinase Cepsilon for their functional regulation in rat brain. , 2009, Biochimica et biophysica acta.

[20]  E. Carboni,et al.  PPAR‐gamma‐mediated neuroprotection in a chronic mouse model of Parkinson’s disease , 2009, The European journal of neuroscience.

[21]  Lawrence R. Frank,et al.  Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis , 2009, NeuroImage.

[22]  Neena Singh,et al.  Abnormal Brain Iron Homeostasis in Human and Animal Prion Disorders , 2009, PLoS pathogens.

[23]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[24]  J. Frackowiak,et al.  Formation of amyloid-β oligomers in brain vascular smooth muscle cells transiently exposed to iron-induced oxidative stress , 2009, Acta Neuropathologica.

[25]  M. Mohan,et al.  Prion Protein Modulates Cellular Iron Uptake: A Novel Function with Implications for Prion Disease Pathogenesis , 2009, PloS one.

[26]  Pramod Kumar,et al.  Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease , 2009, Behavioural Brain Research.

[27]  E. Blalock,et al.  Hippocampal and Cognitive Aging across the Lifespan: A Bioenergetic Shift Precedes and Increased Cholesterol Trafficking Parallels Memory Impairment , 2009, The Journal of Neuroscience.

[28]  W. Klein,et al.  Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers , 2009, Proceedings of the National Academy of Sciences.

[29]  J. del Río,et al.  Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model. , 2009, Biochemical and biophysical research communications.

[30]  A. Hofman,et al.  HFE variants, APOE and Alzheimer's disease: Findings from the population-based Rotterdam Study , 2009, Neurobiology of Aging.

[31]  I. Grundke‐Iqbal,et al.  Mechanisms of tau-induced neurodegeneration , 2009, Acta Neuropathologica.

[32]  G. Ming,et al.  Axonal Protective Effects of the Myelin-Associated Glycoprotein , 2009, The Journal of Neuroscience.

[33]  M. Strong,et al.  Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: Implications for TDP-43 in the physiological response to neuronal injury , 2009, Brain Research.

[34]  J. Luzio,et al.  Spastin Couples Microtubule Severing to Membrane Traffic in Completion of Cytokinesis and Secretion , 2008, Traffic.

[35]  G. Bartzokis,et al.  Brain Volume: Age-Related Changes , 2009 .

[36]  Larry R. Squire,et al.  Encyclopedia of neuroscience , 2009 .

[37]  W. Bowers,et al.  Triple‐transgenic Alzheimer's disease mice exhibit region‐specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology , 2009, Glia.

[38]  K. Jellinger.  Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? , 2009, Acta Neuropathologica.

[39]  B. Pakkenberg,et al.  No change in total length of white matter fibers in Alzheimer's disease , 2008, Neuroscience.

[40]  Masahiko Watanabe,et al.  Loss of hrs in the central nervous system causes accumulation of ubiquitinated proteins and neurodegeneration. , 2008, The American journal of pathology.

[41]  K. Shoumura,et al.  Cellular and subcellular localizations of nonheme ferric and ferrous iron in the rat brain: a light and electron microscopic study by the perfusion-Perls and -Turnbull methods. , 2008, Archives of histology and cytology.

[42]  A. Thomson,et al.  Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease. , 2008, Biochemical Society transactions.

[43]  Ben A. Barres,et al.  Distinct Stages of Myelination Regulated by γ-Secretase and Astrocytes in a Rapidly Myelinating CNS Coculture System , 2008, Neuron.

[44]  B. Ghetti,et al.  Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations , 2008, Molecular Neurodegeneration.

[45]  W. Kim,et al.  Regulation of &agr;-synuclein expression by liver X receptor ligands in vitro , 2008, Neuroreport.

[46]  L. Goldstein,et al.  Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. , 2008, Human molecular genetics.

[47]  P. S. St George-Hyslop,et al.  Loss of γ-Secretase Function Impairs Endocytosis of Lipoprotein Particles and Membrane Cholesterol Homeostasis , 2008, The Journal of Neuroscience.

[48]  M. Pangalos,et al.  Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels , 2008, The Journal of Neuroscience.

[49]  H. Schröder,et al.  IRS‐2 branch of IGF‐1 receptor signaling is essential for appropriate timing of myelination , 2008, Journal of neurochemistry.

[50]  J. Chardigny,et al.  Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters. , 2008, Biochimie.

[51]  F. Villarroya,et al.  Human dendritic cell activities are modulated by the omega‐3 fatty acid, docosahexaenoic acid, mainly through PPARγ:RXR heterodimers: comparison with other polyunsaturated fatty acids , 2008, Journal of leukocyte biology.

[52]  G. Johnson,et al.  Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells , 2008, Journal of Biological Chemistry.

[53]  T. Rohn.  Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease , 2008, Brain Research.

[54]  Osman A. B. S. M. Gani,et al.  Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha. , 2008, Journal of molecular graphics & modelling.

[55]  D. Selkoe,et al.  Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.

[56]  R. Franklin,et al.  Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency , 2008, Nature Neuroscience.

[57]  A. Peters,et al.  The neuroglial population in the primary visual cortex of the aging rhesus monkey , 2008, Glia.

[58]  M. Lagarde,et al.  Effects of docosahexaenoic acid on some megakaryocytic cell gene expression of some enzymes controlling prostanoid synthesis. , 2008, Biochemical and biophysical research communications.

[59]  Mushfiquddin Khan,et al.  Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin , 2008, Journal of neurochemistry.

[60]  B. Trapp,et al.  Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  N. Greig,et al.  Alzheimer's disease drug development in 2008 and beyond: problems and opportunities. , 2008, Current Alzheimer research.

[62]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[63]  Seth Love,et al.  Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.

[64]  T. Montine,et al.  Electrophilic Cyclopentenone Neuroprostanes Are Anti-inflammatory Mediators Formed from the Peroxidation of the ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid* , 2008, Journal of Biological Chemistry.

[65]  J. He,et al.  Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes , 2008, Molecular Psychiatry.

[66]  Sadakazu Aiso,et al.  Nasal Colivelin Treatment Ameliorates Memory Impairment Related to Alzheimer's Disease , 2008, Neuropsychopharmacology.

[67]  R. Morris,et al.  BACE1 gene deletion: Impact on behavioral function in a model of Alzheimer's disease , 2008, Neurobiology of Aging.

[68]  K. Irvine,et al.  Remyelination protects axons from demyelination-associated axon degeneration. , 2008, Brain : a journal of neurology.

[69]  A. Mode,et al.  Effects of the synthetic liver X receptor agonist T0901317 on the growth hormone and thyroid hormone axes in male rats , 2008, Endocrine.

[70]  T. Rusten,et al.  ESCRT functions in autophagy and associated disease , 2008, Cell cycle.

[71]  A. Fagan,et al.  Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease? , 2008, Rejuvenation research.

[72]  C. Ross,et al.  Single Particle Characterization of Iron-induced Pore-forming α-Synuclein Oligomers* , 2008, Journal of Biological Chemistry.

[73]  R. D'Hooge,et al.  Absence of Functional Peroxisomes from Mouse CNS Causes Dysmyelination and Axon Degeneration , 2008, The Journal of Neuroscience.

[74]  A. Peters,et al.  Synapses are lost during aging in the primate prefrontal cortex , 2008, Neuroscience.

[75]  D. Price,et al.  Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice , 2008, Proceedings of the National Academy of Sciences.

[76]  Martin Stangel,et al.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. , 2008, The American journal of pathology.

[77]  C. Geula,et al.  Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease , 2008, Journal of neuropathology and experimental neurology.

[78]  Lili Wang,et al.  Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3β Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing , 2008, The Journal of Neuroscience.

[79]  L. Ricceri,et al.  Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain , 2008, Journal of neuroscience research.

[80]  Douglas B. Ehlenberger,et al.  Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex , 2008, The Journal of comparative neurology.

[81]  R. Franklin,et al.  The biology of CNS remyelination , 2008, Journal of Neurology.

[82]  N. Wilczak,et al.  Insulin-like Growth Factor System Regulates Oligodendroglial Cell Behavior: Therapeutic Potential in CNS , 2008, Journal of Molecular Neuroscience.

[83]  M. Llorens-Martín,et al.  Growth Factors as Mediators of Exercise Actions on the Brain , 2008, NeuroMolecular Medicine.

[84]  K. Selmaj,et al.  Overcoming failure to repair demyelination in EAE: γ-secretase inhibition of Notch signaling , 2008, Journal of the Neurological Sciences.

[85]  D. Geschwind,et al.  A Systems Level Analysis of Transcriptional Changes in Alzheimer's Disease and Normal Aging , 2008, The Journal of Neuroscience.

[86]  P. Mehta,et al.  Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.

[87]  C. Jack,et al.  β‐amyloid burden is not associated with rates of brain atrophy , 2008, Annals of neurology.

[88]  J. Salzer,et al.  Type III neuregulin‐1 promotes oligodendrocyte myelination , 2008, Glia.

[89]  R. Neve,et al.  Hyperoxia Causes Maturation-Dependent Cell Death in the Developing White Matter , 2008, The Journal of Neuroscience.

[90]  A. Yamaguchi,et al.  Biochemical Characterization of Phospholipids, Sulfatide and Heparin as Potent Stimulators for Autophosphorylation of GSK-3β and the GSK-3β-Mediated Phosphorylation of Myelin Basic Protein In vitro , 2007 .

[91]  J. Trojanowski,et al.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations , 2008, Acta Neuropathologica.

[92]  M. Reger,et al.  Intranasal insulin improves cognition and modulates beta-amyloid in early AD. , 2008, Neurology.

[93]  J. Hinman,et al.  Age‐dependent accumulation of ubiquitinated 2′,3′‐cyclic nucleotide 3′‐phosphodiesterase in myelin lipid rafts , 2008, Glia.

[94]  A. Kramer,et al.  Be smart, exercise your heart: exercise effects on brain and cognition , 2008, Nature Reviews Neuroscience.

[95]  D. Hoekstra,et al.  Polarity Development in Oligodendrocytes: Sorting and Trafficking of Myelin Components , 2008, Journal of Molecular Neuroscience.

[96]  J. Repa,et al.  Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse , 2007, The Journal of Neuroscience.

[97]  Jim Mintz,et al.  Apolipoprotein E Affects Both Myelin Breakdown and Cognition: Implications for Age-Related Trajectories of Decline Into Dementia , 2007, Biological Psychiatry.

[98]  H. Arai,et al.  Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies , 2007, Brain Research.

[99]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[100]  D. Edelman,et al.  Serotonin stimulates mitochondrial transport in hippocampal neurons , 2007, Molecular and Cellular Neuroscience.

[101]  D. Graham,et al.  Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans , 2007, Experimental Neurology.

[102]  Peter T Nelson,et al.  Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity , 2007, Journal of neuropathology and experimental neurology.

[103]  A. Isaacs,et al.  Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease , 2007, The Journal of cell biology.

[104]  Oliver Wirths,et al.  Age-dependent axonal degeneration in an Alzheimer mouse model , 2007, Neurobiology of Aging.

[105]  J Wouter Jukema,et al.  Association Between Apolipoprotein E4 and Cognitive Decline in Elderly Adults , 2007, Journal of the American Geriatrics Society.

[106]  Kevin F Krenitsky,et al.  Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia Published, JLR Papers in Press, August 2, 2007. , 2007, Journal of Lipid Research.

[107]  M. Staufenbiel,et al.  Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment , 2007, Molecular Neurodegeneration.

[108]  A. Nazarali,et al.  Transcriptional control of oligodendrogenesis , 2007, Glia.

[109]  J. Sweeney,et al.  White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study. , 2007, Brain : a journal of neurology.

[110]  F. Viana,et al.  Transcriptional Control of Cholesterol Biosynthesis in Schwann Cells by Axonal Neuregulin 1* , 2007, Journal of Biological Chemistry.

[111]  S. Young,et al.  ESCRT-III Dysfunction Causes Autophagosome Accumulation and Neurodegeneration , 2007, Current Biology.

[112]  H. Lassmann,et al.  Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency , 2007, Acta Neuropathologica.

[113]  Manuel Buttini,et al.  Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice* , 2007, Journal of Biological Chemistry.

[114]  F R Ervin,et al.  A primate model for Alzheimer's disease: Investigation of the apolipoprotein E profile of the vervet monkey of St. Kitts , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[115]  H. Mori,et al.  Symmetric Temporal Abnormalities on MR Imaging in Amyotrophic Lateral Sclerosis with Dementia , 2007, American Journal of Neuroradiology.

[116]  Michael P Vitek,et al.  Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions. , 2007, Pharmacogenomics.

[117]  H. Kaneko,et al.  Generation of intracellular domain of insulin receptor tyrosine kinase by γ-secretase , 2007 .

[118]  G. Bartzokis.  Acetylcholinesterase Inhibitors May Improve Myelin Integrity , 2007, Biological Psychiatry.

[119]  P. Somogyi,et al.  Neuronal Diversity in GABAergic Long-Range Projections from the Hippocampus , 2007, The Journal of Neuroscience.

[120]  Chunyu Wang,et al.  γ-Secretase Substrate Concentration Modulates the Aβ42/Aβ40 Ratio , 2007, Journal of Biological Chemistry.

[121]  A. Nordberg.  Amyloid imaging in Alzheimer's disease , 2007, Current opinion in neurology.

[122]  Moussa B. H. Youdim,et al.  Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents , 2007, Progress in Neurobiology.

[123]  P. Eriksson,et al.  Peripheral infusion of insulin-like growth factor-I increases the number of newborn oligodendrocytes in the cerebral cortex of adult hypophysectomized rats. , 2007, Endocrinology.

[124]  A. Mildner,et al.  Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes , 2007, Nature Genetics.

[125]  H. Hagberg,et al.  Delayed IGF-1 Administration Rescues Oligodendrocyte Progenitors from Glutamate-Induced Cell Death and Hypoxic-Ischemic Brain Damage , 2007, Developmental Neuroscience.

[126]  G. Rosoklija,et al.  White matter and cognitive function in schizophrenia. , 2007, The international journal of neuropsychopharmacology.

[127]  Vahram Haroutunian,et al.  Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia. , 2007, The international journal of neuropsychopharmacology.

[128]  S. Heinemann,et al.  GluR7 is an essential subunit of presynaptic kainate autoreceptors at hippocampal mossy fiber synapses , 2007, Proceedings of the National Academy of Sciences.

[129]  F. Gao,et al.  Swim training sensitizes myocardial response to insulin: role of Akt-dependent eNOS activation. , 2007, Cardiovascular research.

[130]  James C. Powell,et al.  The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis. , 2007, Biochemical and biophysical research communications.

[131]  Keith H. Nuechterlein,et al.  Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia , 2007, Schizophrenia Research.

[132]  E. Holzbaur,et al.  Microtubules Tethered at Epithelial Cell Junctions by Dynein Facilitate Efficient Junction Assembly , 2007, Traffic.

[133]  T. Glass,et al.  Associations of salivary cortisol with cognitive function in the Baltimore memory study. , 2007, Archives of general psychiatry.

[134]  George Bartzokis,et al.  Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. , 2007, Brain : a journal of neurology.

[135]  G. Pigino,et al.  Impairments in Fast Axonal Transport and Motor Neuron Deficits in Transgenic Mice Expressing Familial Alzheimer's Disease-Linked Mutant Presenilin 1 , 2007, The Journal of Neuroscience.

[136]  Peter Tontonoz,et al.  Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors , 2007, Proceedings of the National Academy of Sciences.

[137]  D. Small,et al.  The β‐amyloid protein of Alzheimer’s disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor , 2007 .

[138]  J. Andersen,et al.  Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age , 2007, Neurobiology of Aging.

[139]  M. Albert,et al.  Neuropsychological measures in normal individuals that predict subsequent cognitive decline. , 2007, Archives of neurology.

[140]  Helmut Sigel,et al.  Metallomics and the Cell , 2013 .

[141]  M. Elstner,et al.  Individual dopaminergic neurons show raised iron levels in Parkinson disease , 2007, Neurology.

[142]  E. Perry,et al.  Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies , 2007, Neurology.

[143]  A. Delacourte,et al.  Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity , 2007, Proceedings of the National Academy of Sciences.

[144]  Jim Mintz,et al.  Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications , 2007, Neurochemical Research.

[145]  Marinos C. Dalakas,et al.  β‐Amyloid is a substrate of autophagy in sporadic inclusion body myositis , 2007 .

[146]  M. Bhat,et al.  Cytoskeletal transition at the paranodes: the Achilles' heel of myelinated axons. , 2007, Neuron glia biology.

[147]  Hui Zheng,et al.  In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease , 2007, NeuroImage.

[148]  G. Cline,et al.  IGF‐1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination , 2007, Glia.

[149]  Jim Mintz,et al.  Human brain myelination and amyloid beta deposition in Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[150]  V. Thijs,et al.  Association of Apolipoprotein E ϵ2 With White Matter Disease but Not With Microbleeds , 2007 .

[151]  J. Gilley,et al.  Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection. , 2007, Trends in molecular medicine.

[152]  T. Comery,et al.  The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease , 2007, Molecular and Cellular Neuroscience.

[153]  Paul M. Thompson,et al.  Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: Tract-based spatial statistics study of aging , 2007, NeuroImage.

[154]  Christine Stadelmann,et al.  Extensive Cortical Remyelination in Patients with Chronic Multiple Sclerosis , 2007, Brain pathology.

[155]  T. Morgan,et al.  Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. , 2007, Current Alzheimer research.

[156]  D. Rowitch,et al.  Insulin‐like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination , 2007, Glia.

[157]  Jim Mintz,et al.  Brain ferritin iron may influence age- and gender-related risks of neurodegeneration , 2007, Neurobiology of Aging.

[158]  L. Murray-Kolb,et al.  Iron treatment normalizes cognitive functioning in young women. , 2007, The American journal of clinical nutrition.

[159]  D. Dickson,et al.  Journal of Neuroinflammation BioMed Central Review , 2006 .

[160]  T. Kubo,et al.  Increased expression of neuregulin-1 in differentiating muscle satellite cells and in motoneurons during muscle regeneration , 2007, Acta Neuropathologica.

[161]  M. Wolfe.  When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40 , 2007 .

[162]  Jaime Grutzendler,et al.  Various Dendritic Abnormalities Are Associated with Fibrillar Amyloid Deposits in Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[163]  K. Beyreuther,et al.  Axonal accumulation of synaptic markers in APP transgenic Drosophila depends on the NPTY motif and is paralleled by defects in synaptic plasticity , 2007, The European journal of neuroscience.

[164]  B. Lamb,et al.  Spatial and temporal control of age-related APP processing in genomic-based β-secretase transgenic mice , 2007, Neurobiology of Aging.

[165]  W. Klein,et al.  Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease , 2007, The Journal of Neuroscience.

[166]  M. Youdim,et al.  Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease 1 , 2007, Journal of neurochemistry.

[167]  C. van Broeckhoven,et al.  Frontotemporal Lobar Degeneration: Current Concepts in the Light of Recent Advances , 2007 .

[168]  Z. Kouchi,et al.  FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Aβ , 2006, Journal of neurochemistry.

[169]  L. Horrocks,et al.  Modulation of inflammation in brain: a matter of fat , 2006, Journal of neurochemistry.

[170]  Chunyu Wang,et al.  {gamma}-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: IMPLICATIONS FOR ALZHEIMER DISEASE. , 2007, The Journal of biological chemistry.

[171]  D. Small,et al.  The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor. , 2007, Journal of neurochemistry.

[172]  M. Mattson,et al.  Homocysteine and folate deficiency sensitize oligodendrocytes to the cell death-promoting effects of a presenilin-1 mutation and amyloid β-peptide , 2007, NeuroMolecular Medicine.

[173]  M. Mattson,et al.  Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice , 2007, NeuroMolecular Medicine.

[174]  J. Wesson Ashford,et al.  APOE genotype effects on alzheimer’s disease onset and epidemiology , 2007, Journal of Molecular Neuroscience.

[175]  J. Hardy.  Does Aβ 42 Have a Function Related to Blood Homeostasis? , 2007, Neurochemical Research.

[176]  I. Maričić,et al.  Mini Review: Immune Response to Myelin-Derived Sulfatide and CNS-Demyelination , 2007, Neurochemical Research.

[177]  A. Fagan,et al.  Plasma Cortisol and Progression of Dementia in DAT Subjects , 2006 .

[178]  B. Borroni,et al.  APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[179]  A. Fagan,et al.  Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. , 2006, The American journal of psychiatry.

[180]  P. Wong,et al.  Bace1 modulates myelination in the central and peripheral nervous system , 2006, Nature Neuroscience.

[181]  Florence Pasquier,et al.  Phenotype associated with APP duplication in five families. , 2006, Brain : a journal of neurology.

[182]  P. Saftig,et al.  Control of Peripheral Nerve Myelination by the ß-Secretase BACE1 , 2006, Science.

[183]  E. Weeber,et al.  The generation and function of soluble apoE receptors in the CNS , 2006, Molecular Neurodegeneration.

[184]  M Worwood,et al.  Iron genes, iron load and risk of Alzheimer’s disease , 2006, Journal of Medical Genetics.

[185]  Klaus-Armin Nave,et al.  Axonal regulation of myelination by neuregulin 1 , 2006, Current Opinion in Neurobiology.

[186]  I. Ferrer,et al.  Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients: A Biochemical Analysis , 2006 .

[187]  L. Goldstein,et al.  The Genetics of Axonal Transport and Axonal Transport Disorders , 2006, PLoS genetics.

[188]  J. D. McGaugh,et al.  Glucocorticoids Increase Amyloid-β and Tau Pathology in a Mouse Model of Alzheimer’s Disease , 2006, The Journal of Neuroscience.

[189]  T. Montine,et al.  Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity , 2006, Journal of Neuroinflammation.

[190]  Thomas H. Gillingwater,et al.  Synaptic Vulnerability in Neurodegenerative Disease , 2006, Journal of neuropathology and experimental neurology.

[191]  F. Tortella,et al.  Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury , 2006, Journal of neurochemistry.

[192]  W. Brück,et al.  A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. , 2006, Brain : a journal of neurology.

[193]  C. Ward,et al.  In Vivo Restoration of Physiological Levels of Truncated TrkB.T1 Receptor Rescues Neuronal Cell Death in a Trisomic Mouse Model , 2006, Neuron.

[194]  Ahmad Salehi,et al.  Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration , 2006, Neuron.

[195]  I. Björkhem,et al.  Oxysterols and Alzheimer's disease , 2006, Acta neurologica Scandinavica. Supplementum.

[196]  Hui Zheng,et al.  Molecular Neurodegeneration BioMed Central Review The amyloid precursor protein: beyond amyloid , 2006 .

[197]  Marc Dhenain,et al.  In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice , 2006, Neurobiology of Aging.

[198]  N. Reo,et al.  Evidence that Plasmalogen is Protective Against Oxidative Stress in the Rat Brain , 2006, Neurochemical Research.

[199]  J. Chardigny,et al.  Cerebral plasmalogens and aldehydes in senescence-accelerated mice P8 and R1: A comparison between weaned, adult and aged mice , 2006, Brain Research.

[200]  Romana Höftberger,et al.  Transient Axonal Injury in the Absence of Demyelination: A Correlate of Clinical Disease in Acute Experimental Autoimmune Encephalomyelitis , 2006, Acta Neuropathologica.

[201]  L Nyberg,et al.  Altered brain white matter integrity in healthy carriers of the APOE ε4 allele , 2006, Neurology.

[202]  Marc Dhenain,et al.  Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease , 2006, Neurobiology of Disease.

[203]  D. Selkoe,et al.  Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers , 2006, The Journal of physiology.

[204]  A. Peters,et al.  Age‐related molecular reorganization at the node of Ranvier , 2006, The Journal of comparative neurology.

[205]  Jacek Szczygielski,et al.  Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease , 2006, Acta Neuropathologica.

[206]  K. Honke,et al.  Sulfatide is essential for the maintenance of CNS myelin and axon structure , 2006, Glia.

[207]  G. Schellenberg,et al.  Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype , 2006, Neurobiology of Aging.

[208]  Jean-Marie Bonny,et al.  Oligodendrocyte differentiation is increased in transferrin transgenic mice , 2006, Journal of neuroscience research.

[209]  Edith V. Sullivan,et al.  Supratentorial Profile of White Matter Microstructural Integrity in Recovering Alcoholic Men and Women , 2006, Biological Psychiatry.

[210]  R. Martins,et al.  Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. , 2006, AJNR. American journal of neuroradiology.

[211]  D. Kirschner,et al.  Evolution of a neuroprotective function of central nervous system myelin , 2006, The Journal of cell biology.

[212]  C. Finch,et al.  A perspective on sporadic inclusion-body myositis , 2006, Neurology.

[213]  M. Mura,et al.  Dementia, pyramidal system involvement, and leukoencephalopathy with a presenilin 1 mutation , 2006, Neurology.

[214]  M. Ohno,et al.  Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1 , 2006, The European journal of neuroscience.

[215]  P. Morell,et al.  Origin of cholesterol in myelin , 1996, Neurochemical Research.

[216]  G. Rouser,et al.  Curvilinear regression course of human brain lipid composition changes with age , 1968, Lipids.

[217]  Jim Mintz,et al.  Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. , 2006, Archives of general psychiatry.

[218]  J. Connor,et al.  HFE mutations and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[219]  J. Chardigny,et al.  Plasmalogen metabolism-related enzymes in rat brain during aging: influence of n-3 fatty acid intake. , 2006, Biochimie.

[220]  C. Quintana,et al.  Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. , 2006, Journal of structural biology.

[221]  W. Robinson,et al.  Lipid microarrays identify key mediators of autoimmune brain inflammation , 2006, Nature Medicine.

[222]  M. Staufenbiel,et al.  Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice* , 2005, Journal of Biological Chemistry.

[223]  H. Cai,et al.  BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions , 2005, The Journal of Neuroscience.

[224]  N. Inestrosa,et al.  Peroxisomal Proliferation Protects from β-Amyloid Neurodegeneration* , 2005, Journal of Biological Chemistry.

[225]  S. Love,et al.  Contributors to white matter damage in the frontal lobe in Alzheimer's disease , 2005, Neuropathology and applied neurobiology.

[226]  J. Morris,et al.  Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. , 2005, Archives of neurology.

[227]  G. Harauz,et al.  Assembly of tubulin by classic myelin basic protein isoforms and regulation by post-translational modification. , 2005, Biochemistry.

[228]  M. Reger,et al.  Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone: A Preliminary Study , 2005 .

[229]  M. Reger,et al.  Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[230]  E. Englund,et al.  Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease—a neuropathological study , 2005, International journal of geriatric psychiatry.

[231]  B. Schürmann,et al.  The Oral Antidiabetic Pioglitazone Protects from Neurodegeneration and Amyotrophic Lateral Sclerosis-Like Symptoms in Superoxide Dismutase-G93A Transgenic Mice , 2005, The Journal of Neuroscience.

[232]  P. Thibault,et al.  Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein , 2005, The Journal of cell biology.

[233]  W. Gan,et al.  Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2 , 2005, Neuroscience Letters.

[234]  Frank W. Pfrieger,et al.  Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron , 2005, Molecular and Cellular Neuroscience.

[235]  K. Fischbeck,et al.  Distal spinal and bulbar muscular atrophy caused by dynactin mutation , 2005, Annals of neurology.

[236]  K. Nave,et al.  CNP is required for maintenance of axon–glia interactions at nodes of Ranvier in the CNS , 2005, Glia.

[237]  Klaus-Armin Nave,et al.  High cholesterol level is essential for myelin membrane growth , 2005, Nature Neuroscience.

[238]  L. Maffei,et al.  Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[239]  Judes Poirier,et al.  Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease , 2005, Neurobiology of Aging.

[240]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[241]  W. Gan,et al.  Defective Neuromuscular Synapses in Mice Lacking Amyloid Precursor Protein (APP) and APP-Like Protein 2 , 2005, The Journal of Neuroscience.

[242]  G. Pigino,et al.  Polyglutamine expansion diseases: failing to deliver. , 2005, Trends in molecular medicine.

[243]  P. Schoenemann,et al.  Prefrontal white matter volume is disproportionately larger in humans than in other primates , 2005, Nature Neuroscience.

[244]  G. Bartzokis.  BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. , 2005, Adolescent psychiatry.

[245]  M. Musicco,et al.  Metallothionein-I-II and GFAP positivity in the brains from frontotemporal dementia patients. , 2005, Journal of Alzheimer's disease : JAD.

[246]  N. Inestrosa,et al.  Peroxisomal proliferation protects from beta-amyloid neurodegeneration. , 2005, The Journal of biological chemistry.

[247]  R. G. Thorne,et al.  Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration , 2004, Neuroscience.

[248]  Jan Born,et al.  Intranasal insulin improves memory in humans , 2004, Psychoneuroendocrinology.

[249]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[250]  Jaime Grutzendler,et al.  Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches , 2004, Nature Neuroscience.

[251]  J. Haines,et al.  Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis , 2004, Neurogenetics.

[252]  Jane S. Paulsen,et al.  In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease , 2004, Neurology.

[253]  A. Peters,et al.  Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. , 2004, Cerebral cortex.

[254]  Yongcheng Wang,et al.  The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain. , 2004, Molecular cell.

[255]  G. Bartzokis,et al.  Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease , 2004, Neurobiology of Aging.

[256]  D. Holtzman,et al.  Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβ peptides and F2‐isoprostanes in the absence of detectable amyloid deposits , 2004, Journal of neurochemistry.

[257]  J. Dietschy,et al.  Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.

[258]  I. Duncan,et al.  Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia , 2004, The Journal of cell biology.

[259]  J. Garbern,et al.  The myelinated axon is dependent on the myelinating cell for support and maintenance: Molecules involved , 2004, Journal of neuroscience research.

[260]  A. Lovett-racke,et al.  Peroxisome Proliferator-Activated Receptor α Agonists as Therapy for Autoimmune Disease1 , 2004, The Journal of Immunology.

[261]  C. van Broeckhoven,et al.  A novel presenilin 1 mutation associated with Pick's disease but not β‐amyloid plaques , 2004, Annals of neurology.

[262]  J. Wesson Ashford,et al.  ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.

[263]  Steve Meaney,et al.  Brain Cholesterol: Long Secret Life Behind a Barrier , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[264]  Carmen Birchmeier,et al.  Axonal Neuregulin-1 Regulates Myelin Sheath Thickness , 2004, Science.

[265]  A. Aleman,et al.  Insulin-like growth factor-I, cognition and brain aging. , 2004, European journal of pharmacology.

[266]  H. Budka,et al.  Topographical and cytopathological lesion analysis of the white matter in Binswanger’s disease brains , 2004, Acta Neuropathologica.

[267]  R. Balice-Gordon,et al.  Dysmyelinated Lower Motor Neurons Retract and Regenerate Dysfunctional Synaptic Terminals , 2004, The Journal of Neuroscience.

[268]  Ronald J A Wanders,et al.  Functions and biosynthesis of plasmalogens in health and disease. , 2004, Biochimica et biophysica acta.

[269]  N. Cairns,et al.  Amyloid precursor protein mRNA levels in Alzheimer's disease brain. , 2004, Brain research. Molecular brain research.

[270]  A. Nordberg,et al.  Reduced levels of Aβ 40 and Aβ 42 in brains of smoking controls and Alzheimer's patients , 2004, Neurobiology of Disease.

[271]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[272]  Linyin Feng,et al.  Implication of gamma-secretase in neuregulin-induced maturation of oligodendrocytes. , 2004, Biochemical and biophysical research communications.

[273]  B. Engelmann.  Plasmalogens: targets for oxidants and major lipophilic antioxidants. , 2004, Biochemical Society transactions.

[274]  I. Nishimoto,et al.  Amino‐ and carboxyl‐terminal mutants of presenilin 1 cause neuronal cell death through distinct toxic mechanisms: Study of 27 different presenilin 1 mutants , 2004, Journal of neuroscience research.

[275]  George Bartzokis,et al.  Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders , 2004, Neurobiology of Aging.

[276]  G. Bartzokis.  Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[277]  G. Bartzokis,et al.  Cortical gray matter volumes are associated with subjective responses to cocaine infusion. , 2004, The American journal on addictions.

[278]  Stanley I. Rapoport,et al.  Membrane Phospholipid Alterations In Alzheimer's Disease: Deficiency of Ethanolamine Plasmalogens , 1997, Neurochemical Research.

[279]  S. Ando,et al.  Turnover of Myelin Lipids in Aging Brain , 2004, Neurochemical Research.

[280]  H. Braak,et al.  Loss of intracortical myelinated fibers: A distinctive age-related alteration in the human striate area , 2004, Acta Neuropathologica.

[281]  I. Griffiths,et al.  Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene , 2004, Acta Neuropathologica.

[282]  E. Mandelkow,et al.  Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses , 2003, Neurobiology of Aging.

[283]  D. Price,et al.  The β-amyloid-related proteins presenilin 1 and BACE1 are axonally transported to nerve terminals in the brain , 2003, Experimental Neurology.

[284]  S. Xuan,et al.  Insulin-Like Growth Factor (IGF) Signaling through Type 1 IGF Receptor Plays an Important Role in Remyelination , 2003, The Journal of Neuroscience.

[285]  B. Pakkenberg,et al.  Marked loss of myelinated nerve fibers in the human brain with age , 2003, The Journal of comparative neurology.

[286]  David R. Brown,et al.  Generation of hydrogen peroxide from mutant forms of the prion protein fragment PrP121-231. , 2003, Biochemistry.

[287]  P. Lips,et al.  Insulin-like growth factor I (IGF-I) and cognitive decline in older persons , 2003, Neurobiology of Aging.

[288]  Vincent Magnotta,et al.  Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. , 2003, Archives of general psychiatry.

[289]  Alan Peters,et al.  Is there remyelination during aging of the primate central nervous system? , 2003, The Journal of comparative neurology.

[290]  George Perry,et al.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. , 2003, The American journal of pathology.

[291]  Ya Ke,et al.  Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.

[292]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[293]  Rudolph E. Tanzi,et al.  Alzheimer's disease: the cholesterol connection , 2003, Nature Neuroscience.

[294]  Jim Mintz,et al.  Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study , 2003, Biological Psychiatry.

[295]  G. Bartzokis,et al.  White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. , 2003, Archives of neurology.

[296]  P. Coleman,et al.  Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease , 2003, Neurobiology of Disease.

[297]  J. Poirier.  Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. , 2003, Trends in molecular medicine.

[298]  K. Nave,et al.  Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.

[299]  G. Bartzokis,et al.  Biological underpinnings of treatment resistance in schizophrenia: an hypothesis. , 2003, Psychopharmacology bulletin.

[300]  C. Masters,et al.  Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron* , 2002, The Journal of Biological Chemistry.

[301]  D. Peterson,et al.  Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice , 2002, The Journal of Neuroscience.

[302]  D. Price,et al.  Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Aβ Amyloidosis , 2002, The Journal of Neuroscience.

[303]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[304]  Nick C Fox,et al.  Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. , 2002, Neurology.

[305]  K. Heilman,et al.  Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank , 2002, Alzheimer disease and associated disorders.

[306]  George Bartzokis,et al.  Schizophrenia: Breakdown in the Well-regulated Lifelong Process of Brain Development and Maturation , 2002, Neuropsychopharmacology.

[307]  Yu-Min Kuo,et al.  Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease† , 2002 .

[308]  K. Zou,et al.  Apolipoprotein E (ApoE) Isoform-dependent Lipid Release from Astrocytes Prepared from Human ApoE3 and ApoE4 Knock-in Mice* , 2002, The Journal of Biological Chemistry.

[309]  J. Hirrlinger,et al.  Oligodendroglial cells in culture effectively dispose of exogenous hydrogen peroxide: comparison with cultured neurones, astroglial and microglial cells , 2002, Journal of neurochemistry.

[310]  Xianlin Han,et al.  Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.

[311]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[312]  Imran Akram,et al.  Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: Management and treatment import , 2002, American journal of Alzheimer's disease and other dementias.

[313]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[314]  Kristen M Harris,et al.  Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders? , 2002, Brain Research Reviews.

[315]  M. Noble,et al.  Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions. , 2002, Developmental biology.

[316]  Jim Mintz,et al.  Brain maturation may be arrested in chronic cocaine addicts , 2002, Biological Psychiatry.

[317]  A. Fagan,et al.  Human and Murine ApoE Markedly Alters Aβ Metabolism before and after Plaque Formation in a Mouse Model of Alzheimer's Disease , 2002, Neurobiology of Disease.

[318]  Erik A Sistermans,et al.  Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. , 2002, Brain : a journal of neurology.

[319]  H. Damasio,et al.  Humans and great apes share a large frontal cortex , 2002, Nature Neuroscience.

[320]  L. Mei,et al.  Presenilin-dependent γ-Secretase-like Intramembrane Cleavage of ErbB4* , 2002, The Journal of Biological Chemistry.

[321]  J. Wolff,et al.  2′,3′-Cyclic nucleotide 3′-phosphodiesterase: A membrane-bound, microtubule-associated protein and membrane anchor for tubulin , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[322]  M. Missal,et al.  A quantitative analysis of the correlations between eye movements and neural activity in the pretectum , 2002, Experimental Brain Research.

[323]  Á. Pascual-Leone,et al.  Effects of Early Undernutrition on the Brain Insulin‐Like Growth Factor‐I System , 2002, Journal of neuroendocrinology.

[324]  J. Nutt,et al.  Age at onset of Parkinson disease and apolipoprotein E genotypes. , 2002, American journal of medical genetics.

[325]  Alan Peters,et al.  Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey , 2002, The Journal of comparative neurology.

[326]  H. Lassmann,et al.  Endoplasmic Reticulum Stress in PLP‐Overexpressing Transgenic Rats: Gray Matter Oligodendrocytes Are More Vulnerable than White Matter Oligodendrocytes , 2002, Journal of neuropathology and experimental neurology.

[327]  Alan Peters,et al.  Structural changes in the normally aging cerebral cortex of primates. , 2002, Progress in brain research.

[328]  L. Goldstein,et al.  Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP , 2001, Nature.

[329]  R. Nashmi,et al.  Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels , 2001, Brain Research Reviews.

[330]  C. Göritz,et al.  CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.

[331]  T. Golde,et al.  γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase , 2001, Science.

[332]  K. Kitagawa,et al.  Delayed, but Marked, Expression of Apolipoprotein E is Involved in Tissue Clearance after Cerebral Infarction , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[333]  M. J. Wade,et al.  Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. , 2001, Archives of neurology.

[334]  S. Emr,et al.  Ubiquitin-Dependent Sorting into the Multivesicular Body Pathway Requires the Function of a Conserved Endosomal Protein Sorting Complex, ESCRT-I , 2001, Cell.

[335]  Gert Lubec,et al.  Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer’s disease , 2001, Neurobiology of Aging.

[336]  A. Hackshaw,et al.  Neuropathology of inflicted head injury in children. II. Microscopic brain injury in infants. , 2001, Brain : a journal of neurology.

[337]  B. McEwen,et al.  Tracking the estrogen receptor in neurons: Implications for estrogen-induced synapse formation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[338]  Xianlin Han,et al.  Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.

[339]  G. Bartzokis,et al.  Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[340]  Scott T. Brady,et al.  Changes in Microtubule Stability and Density in Myelin-Deficient Shiverer Mouse CNS Axons , 2001, The Journal of Neuroscience.

[341]  J. Dietschy,et al.  Cholesterol metabolism in the brain , 2001, Current opinion in lipidology.

[342]  C. Palmer,et al.  Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains , 2001 .

[343]  O. Bizzozero,et al.  Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath , 2001, Journal of neurochemistry.

[344]  E. D. Muse,et al.  Parameters related to lipid metabolism as markers of myelination in mouse brain , 2001, Journal of neurochemistry.

[345]  A. D'ercole,et al.  Insulin‐like growth factor‐I (IGF‐I) protects myelination from undernutritional insult: Studies of transgenic mice overexpressing IGF‐I in brain , 2000, Journal of neuroscience research.

[346]  Ram K. Sihag,et al.  Local Control of Neurofilament Accumulation during Radial Growth of Myelinating Axons in Vivo , 2000, The Journal of cell biology.

[347]  N. Seidah,et al.  Coordinated Expression of β‐Amyloid Precursor Protein and the Putative β‐Secretase BACE and α‐Secretase ADAM10 in Mouse and Human Brain , 2000 .

[348]  G. Alonso.  Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain , 2000, Glia.

[349]  G. Durand,et al.  Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus , 2000, Neurobiology of Aging.

[350]  J. Gilbert,et al.  Lewy body and Alzheimer pathology in a family with the amyloid-β precursor protein APP717 gene mutation , 2000, Acta Neuropathologica.

[351]  P. Ye,et al.  Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination , 2000, The Journal of Neuroscience.

[352]  H. Lassmann,et al.  Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.

[353]  R. Campenot,et al.  Uptake of Lipoproteins for Axonal Growth of Sympathetic Neurons* , 2000, The Journal of Biological Chemistry.

[354]  S. Rapoport,et al.  Phospholipid composition and levels are altered in down syndrome brain , 2000, Brain Research.

[355]  J. de Vellis,et al.  Dietary iron and the integrity of the developing rat brain: a study with the artificially-reared rat pup. , 2000, Cellular and molecular biology.

[356]  J. Taljaard,et al.  Earlier Age of Onset of Alzheimer's Disease in Patients with Both the Transferrin C2 and Apolipoprotein E‐ɛ4 Alleles , 2000 .

[357]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[358]  J. Ordovás,et al.  Association of apolipoprotein (Apo)E genotype with plasma apo E levels. , 2000, Atherosclerosis.

[359]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[360]  J. Taljaard,et al.  Earlier age of onset of Alzheimer's disease in patients with both the transferrin C2 and apolipoprotein E-epsilon 4 alleles. , 2000, Annals of the New York Academy of Sciences.

[361]  G. Bartzokis,et al.  In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. , 2000, Archives of general psychiatry.

[362]  T. Gotow,et al.  Abnormal expression of neurofilament proteins in dysmyelinating axons located in the central nervous system of jimpy mutant mice , 1999, The European journal of neuroscience.

[363]  B. Anderson,et al.  Anatomic asymmetries of the posterior superior temporal lobes: a postmortem study. , 1999, Neuropsychiatry, neuropsychology, and behavioral neurology.

[364]  R. Franklin,et al.  Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin‐induced CNS demyelination , 1999, Glia.

[365]  M. Frotscher,et al.  Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice , 1999, The Journal of Neuroscience.

[366]  V. Budnik,et al.  The Drosophila β-Amyloid Precursor Protein Homolog Promotes Synapse Differentiation at the Neuromuscular Junction , 1999, The Journal of Neuroscience.

[367]  Virginia M. Y. Lee,et al.  Formation of Compact Myelin Is Required for Maturation of the Axonal Cytoskeleton , 1999, The Journal of Neuroscience.

[368]  T. Révész,et al.  Neuronal cytoskeletal changes are an early consequence of repetitive head injury , 1999, Acta Neuropathologica.

[369]  M. Berry,et al.  In vivo actions of fibroblast growth factor‐2 and insulin‐like growth factor‐I on oligodendrocyte development and myelination in the central nervous system , 1999, Journal of neuroscience research.

[370]  P. Lantos,et al.  Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[371]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[372]  Sarah Tomlin,et al.  Microtechnology: Laying it on thick , 1999, Nature.

[373]  G. Bartzokis,et al.  Increased basal ganglia iron levels in Huntington disease. , 1999, Archives of neurology.

[374]  U. Igbavboa,et al.  Recent advances in brain cholesterol dynamics: Transport, domains, and Alzheimer's disease , 1999, Lipids.

[375]  G. Dallner,et al.  The protective role of plasmalogens in iron-induced lipid peroxidation. , 1999, Free radical biology & medicine.

[376]  M. Garrido,et al.  Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: delayed maturation of auditory brainstem responses. , 1998, The American journal of clinical nutrition.

[377]  É. Vázquez,et al.  MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders , 1998, Neurology.

[378]  D L Rosene,et al.  Feature article: are neurons lost from the primate cerebral cortex during normal aging? , 1998, Cerebral cortex.

[379]  C. Masters,et al.  Relative Increase in Alzheimer’s Disease of Soluble Forms of Cerebral Aβ Amyloid Protein Precursor Containing the Kunitz Protease Inhibitory Domain* , 1998, The Journal of Biological Chemistry.

[380]  J. Growdon,et al.  Structure and Functions of Human Cerebrospinal Fluid Lipoproteins from Individuals of Different APOE Genotypes , 1998, Experimental Neurology.

[381]  R. Nieuwenhuys,et al.  The Central Nervous System of Vertebrates , 1997, Springer Berlin Heidelberg.

[382]  U. Igbavboa,et al.  Lipid Binding to Amyloid β‐Peptide Aggregates: Preferential Binding of Cholesterol as Compared with Phosphatidylcholine and Fatty Acids , 1997, Journal of neurochemistry.

[383]  P. Riederer,et al.  Dramatic increase of α-hydroxyaldehydes derived from plasmalogens in the aged human brain , 1997 .

[384]  B. Trapp,et al.  CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction , 1997, Journal of neuroscience research.

[385]  N. Fujita,et al.  Degeneration of the Pyramidal Tracts in Patients with Amyotrophic Lateral Sclerosis , 1997, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[386]  F. Fazekas,et al.  Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. , 1997, Stroke.

[387]  K. Nave,et al.  Assembly of CNS Myelin in the Absence of Proteolipid Protein , 1997, Neuron.

[388]  P. Riederer,et al.  Dramatic increase of alpha-hydroxyaldehydes derived from plasmalogens in the aged human brain. , 1997, Chemistry and physics of lipids.

[389]  C. Gottfries,et al.  Membrane Components Separate Early-Onset Alzheimer's Disease From Senile Dementia of the Alzheimer Type , 1996, International Psychogeriatrics.

[390]  M. Albert,et al.  Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey , 1996, Journal of neuropathology and experimental neurology.

[391]  H. Braak,et al.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.

[392]  J. Connor,et al.  Relationship of iron to oligondendrocytes and myelination , 1996 .

[393]  Peter E. Braun,et al.  Overexpression of 2′,3′-Cyclic Nucleotide 3′-Phosphodiesterase in Transgenic Mice Alters Oligodendrocyte Development and Produces Aberrant Myelination , 1996, Molecular and Cellular Neuroscience.

[394]  H. Vinters,et al.  Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease , 1996, Acta Neuropathologica.

[395]  P. Ye,et al.  Insulin-like growth factor-I influences the initiation of myelination: studies of the anterior commissure of transgenic mice , 1995, Neuroscience Letters.

[396]  S. Rapoport,et al.  Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain , 1995, Brain Research.

[397]  F. Hefti,et al.  Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons , 1995, Neuron.

[398]  C. Masters,et al.  APP gene family: unique age-associated changes in splicing of Alzheimer's βA4-amyloid protein precursor , 1994, Neurobiology of Disease.

[399]  F. Benes,et al.  Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. , 1994, Archives of general psychiatry.

[400]  B. Gadella,et al.  Metabolic and functional aspects of sulfogalactolipids. , 1994, Biochimica et biophysica acta.

[401]  V. Sapirstein,et al.  Amyloid precursor protein is enriched in axolemma and periaxolemmal‐myelin and associated clathrin‐coated vesicles , 1994, Journal of neuroscience research.

[402]  T. Kemper,et al.  Neuroanatomical and neuropathological changes during aging and dementia. , 1994 .

[403]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[404]  Peter Shrager,et al.  Axonal coding of action potentials in demyelinated nerve fibers , 1993, Brain Research.

[405]  S. Hirai,et al.  Amyloid β protein precursor accumulates in swollen neurites throughout rat brain with aging , 1993, Neuroscience Letters.

[406]  M. Carson,et al.  Insulin-like growth factor I increases brain growth and central nervous system myelination in tTransgenic mice , 1993, Neuron.

[407]  W H Oldendorf,et al.  Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores , 1993, Magnetic resonance in medicine.

[408]  H. Persson,et al.  Myelinated nerve fibres in the CNS , 1993, Progress in Neurobiology.

[409]  E. Masliah,et al.  Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.

[410]  G. Huber,et al.  β‐Amyloid Precursor Protein Isoforms in Various Rat Brain Regions and During Brain Development , 1992 .

[411]  J. Kimura,et al.  Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer's disease and other neurological disorders. , 1992, Brain research. Molecular brain research.

[412]  D. Schiffer,et al.  Age‐related ubiquitin deposits in dystrophic neurites: an immunoelectron microscopic study , 1992, Neuropathology and applied neurobiology.

[413]  A. Hofman,et al.  Epidemiology of Alzheimer's disease. , 1992, Epidemiologic reviews.

[414]  H. Sprecher,et al.  The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. , 1991, The Journal of biological chemistry.

[415]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[416]  D. Dickson,et al.  Ubiquitin‐immunoreactive Dystrophic Neurites in Down's Syndrome Brains , 1991, Journal of neuropathology and experimental neurology.

[417]  J. Goodrum.  Cholesterol from Degenerating Nerve Myelin Becomes Associated with Lipoproteins Containing Apolipoprotein E , 1991, Journal of neurochemistry.

[418]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[419]  A. Peters,et al.  Effects of aging on the neuroglial cells and pericytes within area 17 of the rhesus monkey cerebral cortex , 1991, The Anatomical record.

[420]  J. Morrison,et al.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex , 1990, The Journal of comparative neurology.

[421]  K. Ikeda,et al.  Alzheimer's disease amyloid precursor protein is present in the myelin sheath of central nervous system in rat , 1990, Brain Research.

[422]  D. Dickson,et al.  Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[423]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[424]  A Brun,et al.  White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments , 1990, Histopathology.

[425]  Myrna Espiritu,et al.  Distinct genomic copy number in mitochondria of different mammalian organs , 1990, Journal of cellular physiology.

[426]  P. Rakić,et al.  Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey , 1990, The Journal of comparative neurology.

[427]  G. Dacremont,et al.  Experimental inhibition of peroxisomal β‐oxidation in rats: Influence on brain myelination , 1990, Glia.

[428]  E. Shooter,et al.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.

[429]  Janice E. Knoefel,et al.  Clinical neurology of aging , 1985 .

[430]  J. Thompson,et al.  X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's disease. , 1984, Biochimica et biophysica acta.

[431]  P. Morell,et al.  In Vivo Metabolism of Oligodendroglial Lipids , 1984 .

[432]  Richard P. Bunge,et al.  The Biology of the Oligodendrocyte , 1984 .

[433]  M. Colonnier,et al.  Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: A stereological analysis in normal and monocularly deprived animals , 1982, The Journal of comparative neurology.

[434]  R. Wiggins.  Myelin development and nutritional insufficiency , 1982, Brain Research Reviews.

[435]  A. Meyer,et al.  Paul Flechsig’s System of Myelogenetic Cortical Localization In the Light of Recent Research in Neuroanatomy and Neurophysiology Part II , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[436]  J. Rosenbluth.  Peripheral myelin in the mouse mutant Shiverer , 1980, The Journal of comparative neurology.

[437]  F. Jacob,et al.  Evolution and tinkering. , 1977, Science.

[438]  J. Walton.  Advances in neurology, vol. 1 (Huntington's chorea, 1872–1972) , 1974 .

[439]  T A Sears,et al.  Internodal conduction in undissected demyelinated nerve fibres , 1972, The Journal of physiology.

[440]  G. Rouser,et al.  Lipids in the nervous system of different species as a function of age: brain, spinal cord, peripheral nerve, purified whole cell preparations, and subcellular particulates: regulatory mechanisms and membrane structure. , 1972, Advances in lipid research.

[441]  A. Minkowski,et al.  Regional Development of the Brain in Early Life , 1968 .

[442]  R. Terry,et al.  ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. , 1964, The American journal of pathology.

[443]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[444]  Theodor Kaes,et al.  Die Großhirnrinde des Menschen in ihren Maßen und in ihrem Fasergehalt : ein gehirnanatomischer Atlas , 1907 .